Proteome Sciences (UK) Profile

GBp 0.01  0.27%

Proteome Sciences Summary

Proteome Sciences plc (PRM) is traded on London Stock Exchange in UK. It is located in Hamilton House and employs 34 people. The company currently falls under 'Nano-Cap' category with current market capitalization of 9.74 M. Proteome Sciences plc classifies itself under Healthcare sector and is part of Medical Laboratories and Research industry. This company has 295.18 M outstanding shares. PROTEOME SCIENCES has accumulated about 908 K in cash with (1.7 M) of positive cash flow from operations.
Check Proteome Sciences Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 3.65HorizonTargetOdds Above 3.65
39.00%30 days 3.65 60.61%
Based on normal probability distribution, the odds of Proteome Sciences to move above current price in 30 days from now is about 60.61% (This Proteome Sciences plc probability density function shows the probability of Proteome Sciences Stock to fall within a particular range of prices over 30 days) .

Proteome Sciences plc Risk Profiles

Key Fundamentals

Proteome Sciences Against Markets

Current Ratings

Proteome Sciences 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Proteome Sciences plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers. The company was incorporated in 1993 and is headquartered in London, the United Kingdom. Proteome Sciences operates under Diagnostics Research classification in UK and traded on London Stock Exchange. It employs 34 people. more
NameProteome Sciences plc
CEO, DirectorJeremy HaighView All
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentUK Stock View All
Business AddressHamilton House
ExchangeLondon Stock Exchange
IndustryMedical Laboratories and Research
Phone44 20 7043 2116

Proteome Sciences Corporate Directors

William Dawson Non-Executive Director
Roger McDowell Non-Executive Director
Christopher Pearce Chief Executive, Executive Director
Additionally take a look at Your Equity Center. Please also try Pair Correlation module to compare performance and examine historical correlation between any two equity instruments.